Zymeworks upgraded to Outperform from Market Perform at Leerink
PremiumThe FlyZymeworks upgraded to Outperform from Market Perform at Leerink
2d ago
Jazz Pharmaceuticals Reports Strong Q3 2024 Growth
Premium
Company Announcements
Jazz Pharmaceuticals Reports Strong Q3 2024 Growth
3d ago
Jazz Pharmaceuticals reports Q3 adjusted EPS $6.61, consensus $5.50
Premium
The Fly
Jazz Pharmaceuticals reports Q3 adjusted EPS $6.61, consensus $5.50
3d ago
Court ruling removes ‘last binary risk’ for Avadel, says H.C. Wainwright
PremiumThe FlyCourt ruling removes ‘last binary risk’ for Avadel, says H.C. Wainwright
9d ago
Avadel Pharmaceuticals price target raised to $30 from $29 at Oppenheimer
Premium
The Fly
Avadel Pharmaceuticals price target raised to $30 from $29 at Oppenheimer
9d ago
Avadel announces favorable ruling in admin procedure act litigation
Premium
The Fly
Avadel announces favorable ruling in admin procedure act litigation
9d ago
Jazz Pharmaceuticals presents updated Phase 2 data for zanidatamab
PremiumThe FlyJazz Pharmaceuticals presents updated Phase 2 data for zanidatamab
2M ago
Truist healthcare analyst holds an analyst/industry conference call
Premium
The Fly
Truist healthcare analyst holds an analyst/industry conference call
2M ago
Jazz Pharmaceuticals’ Epidiolex shows efficacy in epilepsy presentations
Premium
The Fly
Jazz Pharmaceuticals’ Epidiolex shows efficacy in epilepsy presentations
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100